Evidence map›Paper›PMID 30141837›Full record

SynthesisCancer2018

Alternative payment and care-delivery models in oncology: A systematic review.

Emeline M Aviki, Stephen M Schleicher, Samyukta Mullangi, Konstantina Matsoukas, Deborah Korenstein

Abstract readSystematic Review
In one paragraph

Synthesis in Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Association Between Spending and Outcomes for Patients With Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emeline M AvikiCenter for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0003-0891-9399
Stephen M SchleicherCenter for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, New York.
Samyukta MullangiDepartment of Medicine, Michigan Medicine, Ann Arbor, Michigan.
Konstantina MatsoukasLibrary Services, Memorial Sloan Kettering Cancer Center, New York, New York.
Deborah KorensteinCenter for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, New York.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Rising US health care costs have led to the creation of alternative payment and care-delivery models designed to maximize outcomes and/or minimize costs through changes in reimbursement and care delivery. The impact of these interventions in cancer care is unclear. This review was undertaken to describe the landscape of new alternative payment and care-delivery models in cancer care. In this systematic review, 22 alternative payment and/or care-delivery models in cancer care were identified. These included 6 bundled payments, 4 accountable care organizations, 9 patient-centered medical homes, and 3 other interventions. Only 12 interventions reported outcomes; the majority (n = 7; 58%) improved value, 4 had no impact, and 1 reduced value, but only initially. Heterogeneity of outcomes precluded a meta-analysis. Despite the growth in alternative payment and delivery models in cancer, there is limited evidence to evaluate their efficacy. Cancer 2018. © 2018 American Cancer Society.

Indexed as

Health Care CostsHealth Care ReformHealth ExpendituresHumansMedical OncologyMedicareNeoplasmsPatient Protection and Affordable Care ActQuality of Health CareReimbursement MechanismsUnited StatesAffordable Care Actalternative care delivery modelsalternative payment modelscancercancer deliveryhealth care deliveryvalue-based cancer carevalue-based health care deliveryvalue-based payment models

Identifiers

PMID30141837
PMCPMC6110102

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.